Subject
Cancer Research,Oncology,Hematology
Reference28 articles.
1. Inhibitory anti-FLT3 antibodies are capable of mediating antibody-dependent cell-mediated cytotoxicity and reducing engraftment of acute myelogenous leukemia blasts in nonobese diabetic/severe combined immunodeficient mice;Piloto;Cancer Res,2005
2. Combination of omacetaxine mepesuccinate (homoharringtonine) and sorafenib as an effective regimen for acute myeloid leukemia (AML) carrying FLT3-ITD;Leung;Blood,2017
3. Clinical relevance of FLT3 receptor protein expression in Indian patients with acute leukemia;Vora;Asia Pac J Clin Oncol,2010
4. The future of targeting FLT3 activation in AML;Leick;Curr Hematol Malig Rep,2017
5. Detailed analysis of FLT3 expression levels in acute myeloid leukemia;Kuchenbauer;Haematologica,2005
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献